Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WEVO Group is a private digital health company focused on mental health assessment, monitoring, and guidance rather than traditional drug development. Public descriptions position WEVO as an artificial intelligence-enabled platform that provides screening, reporting, monitoring, and personalized guidance to support patients, therapists, and other care stakeholders. The company appears to target mental health conditions including anxiety, depression, and post-traumatic stress disorder, with an emphasis on real-time insights and remote access through smartphones and software tools. Available public information suggests it is a healthcare software business rather than a biotech, pharma, or therapeutics developer, and no conventional drug pipeline or clinical-stage therapeutic assets were identified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WEVO Group.